Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Early treatment of COVID-19-related hair loss is crucial for better outcomes.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Early intervention and patient education are crucial for managing alopecia areata.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

Alopecia areata is an autoimmune disease that targets hair follicles.

Alopecia universalis can be an early sign of HIV.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata is linked to reduced T cell function and auto-immunity.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Hair transplant surgery may cause alopecia areata, a new possible complication.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

Alopecia areata doesn't significantly change the risk of common infections.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

A 19-year-old female with alopecia universalis experienced total hair loss, and previous treatments were ineffective.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

COVID-19 doesn't make alopecia areata worse.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

A woman's chronic headaches and hair loss were cured by treating her syphilis.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

Adults with alopecia areata have a higher risk of mental health issues, especially women after COVID-19.